Welcome to CDC stacks | Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus Infection - 7300 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus Infection
Filetype[HTML]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus; Guidelines for using the quantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection
    Personal Author:
    Mazurek, Gerald H.; McDougal, J. Steven; Nicholson, Janet K. A., 1948-; Villarino, Margarita E.;
    Corporate Author:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.; Centers for Disease Control and Preventiom (U.S.); National Center for Infectious Diseases (U.S.); National Center for Infectious Diseases (U.S.), Division of AIDS, STD, and TB Laboratory Research.;
    Published:
    January 31, 2003
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-2
    Description:
    These guidelines were developed by CDC for laboratorians who perform immunophenotyping for detection and enumeration of CD4+ T-cells and other lymphocyte subsets in persons infected with human immunodeficiency virus (HIV). The guidelines describe sin...
    File Type:
    Filetype[PDF - 397.78 KB]
  2. 1997 Revised Guidelines for Performing CD4+ T-cell Determinations in Persons Infected with Human Immunodeficiency Virus (HIV). Centers for Disease Control and Prevention
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-2):1-29.
    Description:
    Human immunodeficiency virus counseling and testing services (HIV-CTS) have been recommended by CDC since 1985, when serologic tests became available to detect antibodies to HIV (1,2). In August 1987, CDC published the Public Health Service Guideline...
    Status:
    superseded
    File Type:
    Filetype[PDF - 311.48 KB]
  3. Guidelines for Performing Single-platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus. Centers for Disease Control and Prevention
    Corporate Author:
    Bureau of HIV/AIDS, STD and TB, Population and Public Health Branch, Health Canada, Ottawa, Ontario, Canada.
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2003; 52(RR-2):1-13.
    Description:
    These guidelines replace CDC's 1995 guidelines, U.S. Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women, and are for public- and private-sector service providers who provide heal...
    Status:
    current
    File Type:
    Filetype[PDF - 397.78 KB]
  4. 1994 Revised Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus (HIV) infections. Centers for Disease Control and Prevention
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1994; 43(RR-3):1-21.
    Description:
    The Food and Drug Administration (FDA) has recommended that all donated blood be screened for antibodies to human immunodeficiency virus type 2 (HIV-2) beginning no later than June 1, 1992. This article provides CDC recommendations for the DIAGNOSIS ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 317.63 KB]
  5. Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection. Centers for Disease Control and Prevention
    Corporate Author:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    January 31, 2003
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2003; 52(RR-2):15-8.
    Description:
    This statement provides new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI) and updates previously published guidelines (1,2). This statement is issued in recognition of the...
    Status:
    superseded
    File Type:
    Filetype[PDF - 397.78 KB]